Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide vs Bariatric Surgery for NASH in Obese Asian Adults
NCT02654665Phase 3Unknown
- Sponsor
- Changi General Hospital
- Start
- Mar 2014
- Primary completion
- Dec 2017
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of liraglutide in Nonalcoholic steatohepatitis (NASH), sponsored by Changi General Hospital. Status: unknown.
02
Drugs
03
Conditions
Nonalcoholic steatohepatitis (NASH)
Beyond the preview
Go deeper on NCT02654665.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02654665.